UNSPSC 51152402: Aspirin/caffeine/orphenadrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class MS200. This VA Drug Class (MS200) classifies this compound as belonging to the group SKELETAL MUSCLE RELAXANTS.

UNSPSC 51152402 Aspirin/caffeine/orphenadrine is a Commodity code with a significant mismatch between its nominal scope and recent state and local procurement activity. The code shows minimal recent activity aligned with its stated pharmaceutical composition; the sole recent opportunity on record is Seminole County, Florida's IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems, which falls entirely outside the aspirin-caffeine-orphenadrine product category. Naloxone is an opioid antagonist used for overdose reversal, and drug deactivation systems are disposal or neutralization products — neither relates to the code's defined pharmaceutical combination.

Seminole County's procurement, posted June 30, 2026, with a response deadline of July 26, 2023, seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and mandates workers' compensation, commercial general liability, and professional liability insurance. Vendors bear all shipping and delivery costs, and the procurement may be FEMA-funded, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The code shows little relevant recent activity; firms evaluating state and local procurement under this UNSPSC designation should confirm the correct commodity code alignment before pursuing opportunities, as the current code appears to be a classification error.